
浏览全部资源
扫码关注微信
纸质出版日期:2016
移动端阅览
杜文霞, 曹俊红, 邱方. 消癥饮治疗子宫内膜异位症临床观察及机制探讨[J]. 中国实验方剂学杂志, 2016,22(19):126-130.
DU Wen-xia, CAO Jun-hong, QIU Fang. Clinical Efficacy and Mechanism of Xiaozheng Yin in Treatment of Endometriosis[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(19): 126-130.
杜文霞, 曹俊红, 邱方. 消癥饮治疗子宫内膜异位症临床观察及机制探讨[J]. 中国实验方剂学杂志, 2016,22(19):126-130. DOI: 10.13422/j.cnki.syfjx.2016190126.
DU Wen-xia, CAO Jun-hong, QIU Fang. Clinical Efficacy and Mechanism of Xiaozheng Yin in Treatment of Endometriosis[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(19): 126-130. DOI: 10.13422/j.cnki.syfjx.2016190126.
目的:探讨消癥饮治疗子宫内膜异位症(EMS)疼痛(气滞血瘀证)的疗效及对基质金属蛋白酶(MMP)-3,MMP-9,血管内皮生长因子(VEGF)和肿瘤坏死因子-α(TNF-α)水平的影响。方法:108例患者随机分成对照组(53例)和观察组(55例)。两组均口服孕三烯酮胶囊,2.5 mg/次,2次/周,连续服用6个月。对照组口服散结镇痛胶囊,4粒/次,3次/d。观察组口服消癥饮,每日1剂。两组每月服药28 d,连续治疗6个月,经期不停药。检测治疗前后血清癌抗原125(CA125)和CA199水平,检测治疗前后血清MMP-3,MMP-9,VEGF和TNF-α水平;进行治疗前后疼痛症状、体征评分和子宫内膜异位症生存质量量表(EHP-5)评分。结果:治疗后观察组视模拟(VAS)、痛经、盆腔痛、盆腔压痛、骶韧带触痛结节评分均显著低于对照组(P<0.01);治疗后观察组CA125和CA199水平明显低于对照组(P<0.05);治疗后观察组血清MMP-3,MMP-9,VEGF,TNF-α水平明显低于对照组(P<0.05,P<0.01);治疗后观察组EHP-5量表疼痛、情绪状态、控制感、性生活、不孕和治疗效果评分显著低于对照组(P<0.01);观察组临床疗效总有效率高于对照组(P<0.05)。结论:消癥饮能显著改善EMS患者疼痛,提高患者生活质量,降低血清CA125,CA199,MMP-3,MMP-9,VEGF和TNF-α水平,从而促进疾病的康复。
Objective: To investigate the efficacy of Xiaozheng Yin for the pain in endometriosis (EMS) with Qi stagnation and blood stasis and observe its effects on levels of matrix metalloproteinase (MMP)-3
MMP-9
vascular endothelial growth factor (VEGF) and tumor necrosis factor-α (TNF-α). Method: One hundred and eight patients were randomly divided into control group (53 cases) and observation group (55 cases). Patients in both groups took Gestrinone capsules
2.5 mg/time
2 times/week
continuing for six months. Patients in control group also took Sanjie Zhentong capsule
4 pieces/time
3 times/day
while patients in observation group orally took Xiaozheng Yin
1 dose/day. Both groups took drugs 28 days a month
continuing for 6 months. Medicines were not withdrawn in menstrual cycle period. The levels of serum cancer antigen 125(CA125) and CA199
levels of serum MMP-3
MMP-9
VEGF and TNF-α were detected before and after treatment. Scores of pain
symptoms and endometriosis health profile-5 (EHP-5) were graded before and after treatment. Result: After therapy
scores of visual analogue scale (VAS)
dysmenorrhea
pelvic pain
pelvic tenderness
and sacral ligament tenderness nodules in observation group were significantly lower than those in control group (P<0.01). After treatment
levels of CA125 and CA199 in observation group were lower than those in control group (P<0.05)
levels of serum MMP-3
MMP-9
VEGF and TNF-α in observation group were less than those in control group (P<0.05
P<0.01)
the scores of pain
emotional state
control
sexual life
infertility and treatment effects at EHP-5 in observation group were significantly lower than those in control group (P<0.01). The total effective rate in treatment group was superior to that in control group (P<0.05). Conclusion: Xiaozheng Yin can obviously improve pain for EMS patients
enhance their quality of life
reduce levels of serum CA125
CA199
MMP-3
MMP-9
VEGF and TNF-α. Therefore
it can promote disease recovery.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621